Evidence map›Paper›PMID 40225966›Full record

ArticleOcular oncology and pathology2025

Female Representation in Ophthalmic Oncology and Pathology: An Analysis of Scholarship and Leadership.

Ogul E Uner, Birkaran Sadhar, Lillian Huang, Maxim Breakstone, Jesse L Berry, Dan S Gombos, Prithvi Mruthyunjaya, Alison H Skalet

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Ocular oncology and pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ogul E UnerCasey Eye Institute, Department of Ophthalmology, Oregon Health and Science University, Portland, OR, USA.
Birkaran SadharLake Erie College of Osteopathic Medicine, Erie, PA, USA.
Lillian HuangCasey Eye Institute, Department of Ophthalmology, Oregon Health and Science University, Portland, OR, USA.
Maxim BreakstoneRobert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA.
Jesse L BerryDepartment of Ophthalmology, Roski Eye Institute, University of Southern California, Los Angeles, CA, USA.
Dan S GombosUniversity of Texas MD Anderson Cancer Center, Houston, TX, USA.
Prithvi MruthyunjayaDepartment of Ophthalmology, Byers Eye Institute, Stanford School of Medicine, Palo Alto, CA, USA.
Alison H SkaletCasey Eye Institute, Department of Ophthalmology, Oregon Health and Science University, Portland, OR, USA.

Funding

Proteomics CoreP30EY010572 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI TED S ACOTT · 1995 to 2026
$19.4M
NEI NIH HHS P30 EY010572
6 · The paper itself

Abstract

Introduction: Female representation in ophthalmic oncology and pathology is unknown. We evaluated gender-based trends in authorship and leadership in these fields, focusing on intraocular tumors. Methods: Articles containing "uveal melanoma" (UM), "retinoblastoma" (Rb), "primary intraocular lymphoma" (PIOL), "choroidal metastasis" (CM), and articles in Results: Among 4,245 UM, 9,660 Rb, 141 PIOL, 353 CM, and 568 OOP authors, more males were first (range, 52-67%) and last authors (range, 69-76%). Analysis of the 4 keywords showed overall female authorship increased from 2011 to 2016 to 2017-2022 (35%-40%, Conclusion: Female representation in ophthalmic oncology and pathology has grown but gender disparities remain. Female first authors were more likely to publish with female last authors. Most society leaders and awardees were male. Cultivating mentorship through professional organizations may help achieve gender parity.

Indexed as

Choroidal metastasisDiversity-Equity-InclusionFemale representationGenderOcular oncologyOcular pathologyOphthalmic oncologyOphthalmic pathologyPrimary intraocular lymphomaRetinoblastomaUveal melanoma

Identifiers

PMID40225966
PMCPMC11991721

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.